June 29 (Reuters) - TBG Diagnostics Ltd (TDL) :
- TBG to acquire controlling equity stake in RBC Biosciences
- TBG to acquire 51% of RBC Biosciences for NT$127 million
- Addition of RBC is expected to double TBG's annual sales revenues to $A8.1
million
News: TDL TBG Diagnostics to acquire controlling equity stake in RBC Biosciences
Add to My Watchlist
What is My Watchlist?